From first collection to commercial launch: Streamlining your supply chain to support next generation therapies

Thursday, May 6th 2021

08:00 PDT; 10:00 CDT; 11:00 EDT; 16:00 BST; 17:00 CEST 

With the surge of innovative cell and gene therapies moving to market, commercial readiness is crucial to successfully delivering these therapies to waiting patients.

As your therapy operations move from early-phase clinical trials to larger populations in late-stage trials and commercialization, your supply chain complexity—and risk—increases. Anticipating common setbacks and actively planning for their solution requires a specialized and collaborative approach with your supply chain partner.

Attend this upcoming webinar for expert insights into strategies that aid in the development of a commercial supply chain for emerging autologous and allogeneic therapies.

  • Proven supply chain strategies that have supported the successful commercial launch of cell and gene therapies
  • Keys to forming and maintaining successful collaborations in cell therapy starting material procurement and management
  • The importance of leveraging partners that have historical expertise and offer comprehensive support across the commercial supply chain
  • Decisions made during clinical development to help anticipate challenges at each phase of advancement and streamline commercialization
Chris McClain, MBA
Senior Vice President, Sales & Business Development
Be The Match BioTherapies
View Biography
Aileen Baquiran
Vice President, Global Supply Chain and Business Operations
Orchard Therapeutics
View Biography
Elisa Manzotti
CEO and Founder
BioInsights Publishing
View Biography

Registration Details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)